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Mortality from gastrointestinal congenital anomalies at 
264 hospitals in 74 low-income, middle-income, and 
high-income countries: a multicentre, international, 
prospective cohort study
Global PaedSurg Research Collaboration*
Summary
Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. 
Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies 
have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of 
the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income 
countries globally, and identified factors associated with mortality.
Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to 
hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, 
exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a 
minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical 
status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary 
intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, 
in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. 
We did a complete case analysis.
Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital 
diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal 
malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middle-
income countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. 
Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). 
Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income 
countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). 
Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in low-
income countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; 
p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients 
combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], 
p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 
[1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention 
(ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety 
checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed 
(ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of 
parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 
[0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality.
Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between low-
income, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will 
be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger 
than 5 years by 2030.
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Introduction
In the past 30 years, major strides have been made in 
reducing childhood mortality globally, with a decrease 
in deaths in children younger than 5 years from 
12·6 million in 1990 to 5·2 million in 2019.1,2 However, 
neonatal mortality has fallen at a slower rate, from 
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4·7 million deaths in 1990 to 2·4 million in 2019.1,2 
Consequently, the proportion of deaths in children 
younger than 5 years occurring in the neonatal period 
has risen from 37% in 1990 to 46% in 2019.2 As 
the number of deaths from infectious diseases has 
decreased, the proportion of deaths attributed to 
congenital anomalies (birth defects) has concurrently 
increased, accounting for an estimated 303 000 neonatal 
deaths and half a million deaths in children younger 
than 5 years annually.3–5 Congenital anomalies are now 
the fifth leading cause of mortality in children younger 
than 5 years and the 11th leading cause of years of life 
lost for the global population.6,7
Congenital anomalies are defined by WHO as structural 
or functional anomalies that occur during intrauterine 
life.4 They affect 3–6% of global live births.4 Low-
income and middle-income countries (LMICs) have the 
highest prevalence due to greater maternal exposure to 
micronutrient deficiencies, teratogens, and intrauterine 
infections, and lower termination rates resulting from 
limited antenatal diagnosis.4,8 LMICs are estimated to 
account for more than 95% of congenital anomaly deaths, 
two-thirds of which could be prevented through surgical 
care. However, these estimates are based on sparse data.5
Data on congenital anomaly outcomes and associated 
factors in LMICs are limited due to a lack of congenital 
anomaly registries, research, and inclusion of these 
conditions within national health surveys.9,10 Through 
international charitable organisations, data have been 
collected on some congenital anomalies, including 
cleft lip and palate, club foot, neural tube defects, and 
congenital heart disease.11–14 However, gastrointestinal 
congenital anomalies, which are also very prevalent, have 
received little attention. These anomalies, which are 
often fatal without access to emergency neonatal surgical 
care, could contribute to a large proportion of the 
preventable congenital anomaly deaths in LMICs.
Sustainable Development Goal 3.2 aims to “end 
preventable deaths of newborns and children under 
5 years of age”.15 Therefore, preventable deaths from 
gastrointestinal congenital anomalies need to be 
identified and quantified globally, and insight must be 
gained into how to improve survival. The aim of this 
study was to prospectively compare the outcomes of 
the seven most common gastrointestinal congenital 
anomalies in low-income, middle-income, and high-
income countries, and to identify factors associated 
with mortality.
Research in context
Evidence before this study
We searched PubMed, Embase, and the Cochrane Central 
Register of Controlled Trials for observational or randomised 
studies published in English from Jan 1, 2000, to Oct 10, 2020. 
Three search strings were used: the seven gastrointestinal 
congenital anomalies included in our study; all-cause 
in-hospital or 30-day postoperative mortality; and patients 
aged under 16 years. Studies were limited to those of primary 
surgical intervention and cohorts of more than 100 patients. 
We found no previous studies that have prospectively 
compared outcomes from gastrointestinal congenital 
anomalies between low-income, middle-income, and 
high-income countries globally. Research on the individual 
conditions was mainly from high-income countries 
(79 studies), with a smaller number of studies from middle-
income countries (14 studies), and one from a low-income 
country. Due to the heterogeneity of the studies, an accurate 
comparison of outcomes between income strata was not 
possible. Information regarding leading causes of death or 
factors associated with mortality for these conditions in 
low-income and middle-income countries (LMICs) is scarce.
Added value of this study
This study provides validated, prospectively collected data on 
patients with gastrointestinal congenital anomalies in 
74 low-income, middle-income, and high-income countries 
across the globe. The results highlight large disparities in 
mortality between income settings. Moreover, the high 
mortality rates identified for these conditions in LMICs far 
exceed surgical mortality rates among older children and adults 
reported in previous international surgical outcomes studies. 
The large study cohort has enabled robust multivariable analysis 
and identification of numerous factors substantially and 
significantly associated with mortality. These results, along with 
the detailed data on patient management in each setting, 
provide a foundation from which interventions, guidelines, 
and policies can be established with the aim of reducing the vast 
inequities in care provision and outcomes that currently exist.
Implications of all the available evidence
Sustainable Development Goal 3.2, which is to end preventable 
deaths of neonates and children under 5 years of age by 2030, 
is unachievable without an urgent focus on improving access to 
quality neonatal surgical care in LMICs. Indicators of clinical 
deterioration before surgical intervention were significantly 
associated with higher mortality for all conditions. Birth at a 
paediatric surgery centre (enabled by antenatal diagnosis) can 
help to prevent this and reduce mortality, as shown in patients 
with gastroschisis and congenital diaphragmatic hernia. 
However, most patients present from district hospitals, 
highlighting the importance of improved diagnosis, 
resuscitation, and timely transfer at this level. At paediatric 
surgery centres, improved provision of basic neonatal intensive 
care facilities, including ventilation, parenteral nutrition, and 
central intravenous access, for neonates could reduce mortality 
further. These interventions would also benefit sick neonates 
more broadly, and therefore would help to further reduce global 
neonatal mortality.
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Methods
Study design and participants
We did a global, multicentre, international, prospective 
cohort study of patients presenting to hospital for 
surgical care with seven gastrointestinal congenital 
anomalies (oesophageal atresia, congenital diaphragmatic 
hernia, intestinal atresia, gastroschisis, exomphalos [also 
known as omphalocele], anorectal malformation, and 
Hirschsprung’s disease). STROBE guidelines were 
followed for this study.
Data were collected by patients’ health-care pro-
viders, including a consultant or senior physician with 
overall clinical responsibility, who also oversaw patient 
recruitment, data completeness, and accuracy. We 
aimed to recruit as many participating hospitals as 
possible from across the world. Local investigators were 
invited to participate through international conference 
presentations, professional organisations, social media, 
and via a network of national and regional study leads. 
Participation was voluntary; no payment was made for 
data collection. Hospital teams chose one calendar 
month (commencing on the first day of the month) or 
multiple 1-month study periods (depending on local 
capacity), between October, 2018, and April, 2019, 
inclusive, to recruit consecutive patients to the study (by 
date of presentation).
Patients included any child younger than 16 years 
presenting acutely, for the first time, with one or more of 
the study conditions, and who received primary surgical 
intervention, conservative treatment, or palliative care. 
Patients were excluded if they had previously had surgery 
for their condition, were returning with a postoperative 
complication, were presenting electively, or were being 
transferred elsewhere for surgical intervention.
This study was classified as a clinical audit, with 
written confirmation from King’s College London Ethics 
Committee that it, therefore, does not require ethical 
approval. All participating centres gained local study 
approval to participate according to their institutional 
ethical regulations. Consent forms were completed by 
all patients in hospitals requiring them. Data transfer 
agreements were legally signed between institutions 
where required.
Procedures
The study protocol, data collection forms, and all 
supporting documentation were produced in 12 lan-
guages.16 Anonymous, de-identified data were collected 
using the secure online platform REDCap.17 A pilot study 
to optimise data collection procedures was done in 
16 hospitals (in 13 countries). Variables were chosen 
based on published core outcome sets and commonly 
collected outcomes in systematic reviews from high-
income countries, as well as important variables 
identified in LMIC literature.18
Generic variables collected for all patients included: 
demographics, antenatal care (maternal ultrasound) and 
diagnosis, delivery type (vaginal or caesarean section), 
transportation (ambulance, patient’s own, or born at 
study hospital), referral site if applicable (district hospital, 
community clinic, home, or other), clinical condition 
on arrival (sepsis, hypovolaemia, or hypothermia), 
resuscitation on arrival (antibiotics, intravenous fluid, or 
warming), clinical condition at surgery (American 
Society of Anesthesiologists [ASA] score), intraoperative 
care (surgical safety checklist used, anaesthetist and 
surgeon grade or position, and anaesthetic admin-
istered), perioperative care (ventilation, intravenous 
access, parenteral nutrition, blood transfusion, and 
antibiotics), and outcomes (detailed later). Condition-
specific variables included: condition type or classifica-
tion, surgical intervention, and com plications. Patients 
were followed up until 30 days after the primary 
intervention, or 30 days after admission in patients who 
did not receive an intervention. The presence and type 
of follow-up was collected for patients discharged before 
30 days.
Clear definitions are provided for all variables in the 
published protocol.18 Internationally utilised and validated 
definitions were used where available. Cause of death was 
decided by the clinical team using 16 predetermined 
categories and one free-text category. From the free-text 
responses, one additional category was added (syndrome 
incompatible with life). Participating country name was 
collected, and World Bank 2018 country income status 
classification was used to categorise countries as low-
income, middle-income, or high-income.19
Data validation was done in 10% of randomly selected 
participating hospitals with use of an independent 
validating local investigator, who retrospectively collected 
a selection of the data again for a 1-month study period. 
The validation data collected included the number of 
eligible patients, generic variables (month of presenta-
tion, study condition, sex, unplanned inter ventions, and 
survival to discharge), and condition-specific variables 
(condition type and surgical intervention). All local 
investigators at validation hospitals completed a data 
accuracy question naire to help identify potential errors 
and aid data interpretation.
Outcomes
The primary outcome was all-cause, in-hospital mortality 
for all conditions combined and each condition 
individually, stratified by country income (low-income, 
middle-income, or high-income). Patients were catego-
rised as alive if they were either discharged alive or were 
still in hospital 30 days after primary intervention or 
30 days after admission for patients who did not receive 
an intervention. Patients were categorised as dead if 
they died in hospital within 30 days of the primary 
intervention or 30 days after admission for patients who 
did not receive an intervention.
Secondary outcomes were the presence of one or more 
of surgical site infection, wound dehiscence, or a need 
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for unplanned reintervention, within 30 days of surgery, 
and 30-day post-primary intervention mortality. Length 
of hospital stay was recorded for all patients (including 
admission and discharge day, up to a 30-day maximum). 
Cause of death was an exploratory outcome.
The study aimed to test our hypothesis that there is a 
significant difference in mortality from the seven most 
common gastrointestinal congenital anomalies between 
low-income, middle-income, and high-income countries 
globally.
Statistical analysis
A sample size calculation was done using Bonferroni 
correction for multiple testing, assuming 80% power and 
an overall type 1 error of 5% (appendix p 13). To determine 
a significant difference in mortality between high-income 
countries and LMICs, the minimum sample size per 
country income group was estimated to be 21 for 
oesophageal atresia, 63 for congenital diaphragmatic 
hernia, 24 for intestinal atresia, 15 for gastroschisis, 
115 for exomphalos, 85 for anorectal malformation, and 
79 for Hirschsprung’s disease (804 patients in total). A 
comparison of mortality between high-income countries, 
middle-income countries, and low-income countries was 
planned if a sufficient cohort was collected.
We did a complete case analysis. Duplicate entries were 
identified and excluded. Patients missing the study 
condition or primary outcome were excluded. If more 
than 20% of patients were missing the primary outcome 
in any given month at a participating hospital, all patients 
in that month were excluded. Data are presented as 
means with SDs if normally distributed and medians 
with IQRs if skewed; count data are presented as numbers 
and percentages. Data are summarised for all patients 
and by country income status. We calculated differences 
in patient demographics, care received, and primary and 
secondary outcomes, between country income strata 
using χ² analysis or Fisher’s exact test if a group had less 
than five patients. p<0·05 was deemed statistically 
significant. Mortality is presented by country income 
status for all patients and for each condition separately, 
with 95% CIs (calculated using the Wald CI for a 
proportion formula when n>5 or exact binomial 
confidence intervals when n≤5).
Continuous variables were used as collected (ie, 
they were not categorised). Categorical variables were 
collapsed to include at least 15 patients per group if 
clinically and statistically appropriate (appendix pp 47–62). 
We combined hypovolaemia, hypothermia, or both on 
admission into one variable due to collinearity.
Three multilevel, multivariable models were used to 
identify factors associated with mortality in all study 
patients (including income status as a covariable), and 
in LMIC and high-income country settings separately. 
All models excluded duration of hospital stay due to 
missing data (n=308) and variable subgroups (time to 
primary intervention; and time to first and full enteral 
feeding, and antibiotic duration, following primary 
intervention). The models containing all patients and 
those from LMICs included all other generic variables. 
Three additional variables from the high-income 
countries model were excluded due to low or no patients 
in a group: anaesthetic type, surgeon grade or position, 
and wound dehiscence (appendix pp 47–48). All 
variables included within the models had a maximum 
of 0·2% missing data (appendix pp 47–62). In the 
multivariable models, patients with missing data for 
one or more entries were excluded. Through the use of 
dummy variables that indicate when a data point is 
missing, we tested and concluded that the small 
amount of missing data did not affect the multivariable 
outcomes. There were no significant differences in the 
mortality between the patients included in the models 
and the small groups that were excluded due to missing 
data. Similarly, there were no significant differences in 
the proportion of patients from high-income, middle-
income, and low-income countries in the patients 
included in the models and the small groups excluded 
due to missing data. Therefore, missing data imputation 
was not done.
All models were adjusted for hospital-level clustering 
and included potential confounders (gestational age at 
birth, bodyweight and age at presentation, presence of 
additional anomalies, and ASA score at primary 
intervention) and effect modifiers (receipt of ventilation, 
central intravenous access, and parenteral nutrition). 
Patients who had no surgical intervention, and therefore 
had no data on ASA score, anaesthetic, anaesthetist, 
surgeon, surgical safety checklist, or secondary outcome 
complications were included in the models (categorised 
as not applicable within each variable) to avoid bias, 
because these patients were either palliated or well 
enough to be managed without emergency intervention. 
We used penalised Lasso regression to determine the 
risk ratio (RR; 95% CI, p value) of mortality for each 
variable within the models. This method was chosen 
over the originally planned logistic regression with 
backwards stepwise elimination to enable more 
variables to be included in the models, with greater 
robustness. Our large cohort size made this technique 
feasible.
Exploratory penalised Lasso regression analyses 
were done for each condition separately, with income 
status as a covariable, adjustments for hospital-level 
clustering, and with the aforementioned confounders 
and effect modifiers included. Models included both 
generic and condition-specific variables. Variables 
excluded due to no or low counts are detailed in the 
appendix (pp 49–62). All multivariable results are 
presented as forest plots.
We compared the validation data with the original 
study data collected using a weighted κ statistic to 
determine level of agreement; observed agreement was 
also reported. We analysed the data using STATA 15.
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The study protocol was registered with ClinicalTrials.gov, 
NCT03666767, and was published previously.18
Role of the funding source
The funder had no role in the study design, data collection, 
data analysis, data interpretation, or writing of the report.
Results
We included 3849 patients with 3975 study conditions 
from 264 hospitals in 74 countries (figures 1, 2) over 
962 1-month study periods (median 3 months per 
hospital [IQR 2–5]). Of the 3849 patients, 2231 (58·0%) 
were male (table 1). Median gestational age at birth 
was 38 weeks (36–39) and median bodyweight at 
presentation was 2·8 kg (2·3–3·3); both characteristics 
were similar across income groups. Similar proportions 
of patients presented with oesophageal atresia, intestinal 
atresia, exomphalos, and Hirschsprung’s disease across 
all income settings, but significantly fewer patients 
presented with congenital diaphragmatic hernia and 
gastroschisis in LMICs compared with high-income 
countries, and significantly more presented with anorectal 
malformation. Fewer patients in low-income countries 
(n=24, 25·8%) had an additional anomaly diagnosed 
compared with middle-income countries (n=1306, 45·7%) 
and high-income countries (n=448, 50·0%).
Median age at presentation was 72 h (IQR 16–192) in 
low-income countries, 24 h (3–96) in middle-income 
countries, and 3 h (0–28) in high-income countries. 
Neonates accounted for 90% (n=3464) of the study 
participants at presentation; the other 10% ranged from 
29 days to 15·8 years of age. Patients travelled further 
from home to the study hospital in low-income countries 
(median distance of 55 km [10–133]) compared with 
middle-income countries (30 km [5–110]) and high-income 
countries (11 km [0–64]). Higher proportions of patients 
presented with sepsis, hypovolaemia, and hypothermia 
in low-income countries and middle-income countries 
compared with high-income countries. A higher propor-
tion of patients did not receive a surgical intervention 
in low-income countries (n=26, 28·0%) compared 
with middle-income countries (n=307, 10·7%) and high-
income countries (n=62, 6·9%); consequently, these 
patients did not have an ASA score. Among patients who 
received an intervention, an ASA score of 1 was most 
prevalent in low-income countries, an ASA score of 2 was 
most prevalent in middle-income countries, and an ASA 
score of 3 was most prevalent in high-income countries.
Nine (9·7%) of 93 patients had their condition 
diagnosed or a problem identified antenatally in low-
income countries compared with 823 (28·8%) of 2860 in 
middle-income countries and 506 (56·5%) of 896 in 
high-income countries (table 2). In low-income countries, 
most patients (n=75, 80·7%) were born via vaginal 
delivery and few (n=15, 16·1%) via caesarean section. 
Figure 1: Global distribution of participating hospitals








Figure 2: Flow diagram of patient inclusion in the study
3999 patient records available for analysis
150 patients excluded 
5 duplicate entries
47 missing consent
59 missing primary outcome
37 from a site with >20% missing primary 
outcome in one given month (14 months 
excluded)
2 missing study condition
3849 patients from 264 hospitals in 74 countries 
included in analysis
High-income countries:
896 patients from 89 hospitals 
in 24 countries
Middle-income countries: 
2860 patients  from
166 hospitals in 44 countries
Low-income countries: 
93 patients from 9 hospitals in 
6 countries
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By contrast, 1421 (49·7%) patients in middle-income 
countries and 411 (45·8%) in high-income countries were 
born via caesarean section. Only two (2·2%) patients 
from low-income countries were born at the paediatric 
surgery centre, compared with 618 (21·6%) in middle-
income countries and 391 (43·6%) in high-income 
countries. In all settings, the majority of outborn 
patients (born outside the paediatric surgery centre) 
presented from district hospitals. In low-income 
countries, 41 (45·1%) patients travelled to the study 
centre using non-hospital transport, compared with 
1041 (46·4%) in middle-income countries and 74 (14·7%) 
in high-income countries.
Some septic and hypovolaemic patients did not receive 
intravenous antibiotics (nine [37·5%] of 24 in low-
income countries; 144 [24·1%] of 598 in middle-
income countries; seven [18·4%] of 38 in high-income 
countries) or intravenous fluids (five [45·5%] of 11 in 
low-income countries; 84 [17·6%] of 478 in middle-
income countries; 34 [45·3%] of 75 in high-income 
countries) within 1 h of presentation, and some 
hypothermic patients were not warmed (28 [7·8%] in 
middle-income countries; four [12·5%] in high-income 
countries). Only 55 (59·1%) of 93 patients in low-
income countries received a general anaesthetic (of 
which 32 [34·4%] did not receive a general anaesthetic 
because they did not have surgery), compared with 
2327 (81·3%) of 2860 in middle-income countries 
and 772 (86·2%) of 896 in high-income countries. 
Anaesthesia was more frequently provided by a 
nurse in low-income countries (n=17, 18·3%) than in 
middle-income countries (n=17, 0·6%) and high-income 
countries (n=1, 0·1%), and surgery was more fre-
quently performed by a general surgeon or unsupervised 
trainee (low-income countries, n=13 [14·0%]; middle-
income countries, n=54 [1·9%]; high-income countries, 
n=14 [1·6%]). A surgical safety checklist was used less 
frequently in low-income countries (n=31, 33·3%) than 
in middle-income countries (n=1791, 62·6%) and high-
income countries (n=747, 83·4%).
In low-income countries, only eight (8·6%) patients 
received ventilation, three (3·2%) received parenteral 
nutrition, and six (6·5%) had central intravenous 
access, compared with much higher proportions in 
middle-income countries (1363 [47·7%] received ventila-
tion, 1416 [49·5%] received parenteral nutrition, and 
1263 [44·2%] had central venous access) and high-income 
countries (637 [71·1%], 683 [76·2%], and 670 [74·8%]).
Condition-specific patient characteristics, antenatal 
care, perioperative care, surgical intervention, and 
outcomes are detailed in the appendix (pp 16–44). In 
high-income countries, where 849 (94·8%) of 896 women 
received an antenatal ultrasound, antenatal detection 
rates (problem identified with or without diagnosis of 
condition) were: 134 (96·4%) of 139 for gastroschisis, 
65 (92·9%) of 70 for exomphalos, 108 (71·1%) of 152 for 














Male 2231 (58·0%) 528 (58·9%) 1655 (57·9%) 48 (51·6%) 0·39
Female 1596 (41·5%) 367 (41·0%) 1185 (41·4%) 44 (47·3%) ··
Ambiguous genitalia 21 (0·5%) 1 (0·1%) 19 (0·7%) 1 (1·1%) ··
Unknown 1 (<0·1%) 0 1 (<0·1%) 0 ··
Gestational age at birth, 
weeks
38 (36–39) 38 (36–39) 38 (36–39) 37 (36–39) 0·76
Bodyweight at 
presentation, kg
2·8 (2·3–3·3) 2·9 (2·4–3·4) 2·8 (2·3–3·3) 2·8 (2·2–3·5) 0·13
Study condition
Oesophageal atresia 560 (14·5%) 141 (15·7%) 412 (14·4%) 7 (7·5%) 0·093
Congenital 
diaphragmatic hernia
448 (11·6%) 148 (16·5%) 299 (10·5%) 1 (1·1%) <0·0001
Intestinal atresia 681 (17·7%) 152 (17·0%) 509 (17·8%) 20 (21·5%) 0·53
Gastroschisis 453 (11·8%) 139 (15·5%) 304 (10·6%) 10 (10·8%) 0·0004
Exomphalos 325 (8·4%) 70 (7·8%) 241 (8·4%) 14 (15·1%) 0·057
Anorectal 
malformation
991 (25·7%) 178 (19·9%) 788 (27·6%) 25 (26·9%) 0·0003
Hirschsprung’s disease 517 (13·4%) 107 (11·9%) 393 (13·7%) 17 (18·3%) 0·15
Additional anomaly or 
study condition 
diagnosed
1778 (46·2%) 448 (50·0%) 1306 (45·7%) 24 (25·8%) <0·0001
Age at presentation, h 22 (1–85) 3 (0–28) 24 (3–96) 72 (16–192) 0·0001
Distance from patient’s 
home to study hospital, 
km
25 (2–100) 11 (0–64) 30 (5–110) 55 (10–133) <0·0001
Sepsis status on arrival to study centre
Yes 660 (17·1%) 38 (4·2%) 598 (20·9%) 24 (25·8%) <0·0001
Missing 3 (0·1%) 1 (0·1%) 2 (0·1%) 0 (0·0%) ··
Hypovolaemia status on arrival to study centre
Yes 564 (14·7%) 75 (8·4%) 478 (16·7%) 11 (11·8%) <0·0001
Missing 4 (0·1%) 1 (0·1%) 2 (0·1%) 1 (1·1%) ··
Hypothermia status on arrival to study centre
Yes 403 (10·5%) 32 (3·6%) 358 (12·5%) 13 (14·0%) <0·0001
Missing 6 (0·2%) 1 (0·1%) 4 (0·1%) 1 (1·1%) ··
ASA score at time of primary intervention
1 (healthy person) 678 (17·6%) 115 (12·8%) 534 (18·7%) 29 (31·2%) <0·0001
2 (mild systemic 
disease)
1195 (31·0%) 260 (29·0%) 914 (32·0%) 21 (22·6%) ··
3 (severe systemic 
disease)
1046 (27·2%) 316 (35·3%) 717 (25·1%) 13 (14·0%) ··
4 (severe systemic 
disease that is a 
constant threat to life
375 (9·7%) 122 (13·6%) 249 (8·7%) 4 (4·3%) ··
5 (moribund patient 
who is not expected to 
survive without the 
operation)




395 (10·3%) 62 (6·9%) 307 (10·7%) 26 (28·0%) ··
Missing 9 (0·2%) 6 (0·7%) 3 (0·1%) 0 ··
Data are n (%) or median (IQR). ASA=American Society of Anesthesiologists. *p values represent univariable testing 
between country income strata. †These patients were either palliated, managed conservatively, or discharged 
without intervention with planned future intervention (appendix pp 16–44).
Table 1: Patient characteristics
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Antenatal care, delivery, transportation to the paediatric surgery centre, and referral site
Antenatal ultrasound
Yes, study condition diagnosed 881 (22·9%) 368 (41·1%) 512 (17·9%) 1 (1·1%) <0·0001
Yes, problem identified but study condition not diagnosed 457 (11·9%) 138 (15·4%) 311 (10·9%) 8 (8·6%) ··
Yes, no problem identified 1945 (50·5%) 343 (38·3%) 1551 (54·2%) 51 (54·8%) ··
No 558 (14·5%) 44 (4·9%) 482 (16·9%) 32 (34·4%) ··
Missing 8 (0·2%) 3 (0·3%) 4 (0·1%) 1 (1·1%) ··
Gestational age of study condition diagnosis if antenatal, weeks 25 (20–31) 21 (16–27) 28 (21–32) ·· 0·0002
Type of delivery
Vaginal (spontaneous) 1767 (45·9%) 373 (41·6%) 1324 (46·3%) 70 (75·3%) <0·0001
Vaginal (induced) 194 (5·0%) 97 (10·8%) 92 (3·2%) 5 (5·4%) ··
Caesarean section (elective) 1022 (26·6%) 185 (20·6%) 830 (29·0%) 7 (7·5%) ··
Caesarean section (urgent or non-elective) 825 (21·4%) 226 (25·2%) 591 (20·7%) 8 (8·6%) ··
Unknown 37 (1·0%) 14 (1·6%) 21 (0·7%) 2 (2·2%) ··
Missing 4 (0·1%) 1 (0·1%) 2 (0·1%) 1 (1·1%) ··
Born at the study hospital
Yes 1011 (26·3%) 391 (43·6%) 618 (21·6%) 2 (2·2%) <0·0001
Missing 5 (0·1%) 1 (0·1%) 4 (0·1%) 0 (0·0%) ··
Mode of transport to hospital if born elsewhere
Ambulance or other transport provided by the health service 1677 (59·1%) 430 (85·1%) 1197 (53·4%) 50 (54·9%) <0·0001
Patient’s own transport 1156 (40·7%) 74 (14·7%) 1041 (46·4%) 41 (45·1%) ··
Missing 5 (0·2%) 1 (0·2%) 4 (0·2%) 0 ··
Location from which patient presented if born elsewhere
District hospital 1835 (64·7%) 401 (79·4%) 1377 (61·4%) 57 (62·6%) <0·0001
Home 504 (17·8%) 51 (10·1%) 445 (19·8%) 8 (8·8%) ··
Community clinic or general practice 446 (15·7%) 44 (8·7%) 379 (16·9%) 23 (25·3%) ··
From another country 7 (0·2%) 3 (0·6%) 4 (0·2%) 0 ··
From a different specialty within the hospital 5 (0·2%) 4 (0·8%) 0 1 (1·1%) ··
Unknown 33 (1·2%) 1 (0·2%) 30 (1·3%) 2 (2·2%) ··
Missing 8 (0·3%) 1 (0·2%) 7 (0·3%) 0 ··
Care at the paediatric surgery centre
Resuscitation on arrival
Administration of appropriate antibiotics if septic
n 660 38 598 24 ··
Yes, within 1 h of arrival 500 (75·8%) 31 (81·6%) 454 (75·9%) 15 (62·5%) 0·42
Yes, within the first day of arrival 150 (22·7%) 7 (18·4%) 135 (22·6%) 8 (33·3%) ··
No 10 (1·5%) 0 9 (1·5%) 1 (4·2%) ··
Administration of intravenous fluid if hypovolaemic
n 564 75 478 11 ··
Yes, within 1 h of arrival 440 (78·0%) 40 (53·3%) 394 (82·4%) 6 (54·5%) <0·0001
Yes, within the first day of arrival 104 (18·4%) 24 (32·0%) 76 (15·9%) 4 (36·4%) ··
No 19 (3·4%) 10 (13·3%) 8 (1·7%) 1 (9·1%) ··
Missing 1 (0·2%) 1 (1·3%) 0 0 ··
Quantity of intravenous fluid given if hypovolaemic
n 564 75 478 11 ··
10–20 mL/kg 408 (72·3%) 36 (48·0%) 363 (75·9%) 9 (81·8%) <0·0001
>20 mL/kg 135 (23·9%) 28 (37·3%) 106 (22·2%) 1 (9·1%) ··
Missing 21 (3·7%) 11 (14·7%) 9 (1·9%) 1 (9·1%) ··
(Table 2 continues on next page)
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(Continued from previous page)
Warming of patient to within normal range on arrival if hypothermic
n 403 32 358 13 ··
Yes 371 (92·1%) 28 (87·5%) 330 (92·2%) 13 (100·0%) 0·35
Primary intervention
Time from arrival at study hospital to primary intervention, h 24 (7–66) 22 (5–48) 24 (8–72) 34 (10–96) 0·0001
Type of anaesthesia used for primary intervention
General anaesthesia with endotracheal tube or laryngeal airway 3154 (81·9%) 772 (86·2%) 2327 (81·3%) 55 (59·1%) <0·0001
Intervention without anaesthesia and with or without analgesia 248 (6·4%) 67 (7·5%) 178 (6·2%) 3 (3·2%) ··
Local anaesthesia only 25 (0·6%) 1 (0·1%) 24 (0·8%) 0 ··
Spinal or caudal anaesthesia 19 (0·5%) 0 19 (0·7%) 0 ··
Ketamine anaesthesia 9 (0·2%) 1 (0·1%) 5 (0·2%) 3 (3·2%) ··
Not applicable (no surgery or primary intervention) 392 (10·2%) 55 (6·1%) 305 (10·7%) 32 (34·4%) ··
Missing 2 (0·1%) 0 2 (0·1%) 0 ··
Person delivering anaesthetic for primary intervention
Anaesthetic doctor 3115 (80·9%) 741 (82·7%) 2336 (81·7%) 38 (40·9%) <0·0001
Medical officer, surgeon, or other health-care professional 86 (2·3%) 42 (4·7%) 41 (1·5%) 3 (3·2%) ··
Anaesthetic nurse 35 (0·9%) 1 (0·1%) 17 (0·6%) 17 (18·3%) ··
No anaesthetic 610 (15·8%) 112 (12·5%) 463 (16·2%) 35 (37·6%) ··
Missing 3 (0·1%) 0 3 (0·1%) 0 ··
Person delivering primary intervention
Paediatric surgeon (or junior with paediatric surgeon assisting or 
in the room)
3345 (86·9%) 825 (92·1%) 2474 (86·5%) 46 (49·5%) <0·0001
Junior doctor or other (without a paediatric or general surgeon 
assisting or in the room)
59 (1·5%) 7 (0·8%) 49 (1·7%) 3 (3·2%) ··
Trainee surgeon (without a paediatric or general surgeon 
assisting or in the room)
49 (1·3%) 7 (0·8%) 36 (1·3%) 6 (6·5%) ··
General surgeon (or junior with general surgeon assisting or in 
the room)
32 (0·8%) 7 (0·8%) 18 (0·6%) 7 (7·5%) ··
Not applicable (no surgery or primary intervention) 361 (9·4%) 49 (5·5%) 281 (9·8%) 31 (33·3%) ··
Missing 3 (0·1%) 1 (0·1%) 2 (0·1%) 0 ··
Surgical safety checklist used at the time of primary intervention
Yes 2569 (66·7%) 747 (83·4%) 1791 (62·6%) 31 (33·3%) <0·0001
No 693 (18·0%) 39 (4·4%) 626 (21·9%) 28 (30·1%) ··
Not applicable (no surgical intervention) 584 (15·1%) 109 (12·1%) 441 (15·4%) 34 (36·5%) ··
Missing 3 (0·1%) 1 (0·1%) 2 (0·1%) 0 ··
Perioperative care
Patient received central venous access
Yes, peripherally inserted central catheter 1120 (29·1%) 436 (48·7%) 678 (23·7%) 6 (6·5%) <0·0001
Yes, percutaneously inserted central line 415 (10·8%) 187 (20·9%) 228 (8·0%) 0 <0·0001
Yes, umbilical catheter 402 (10·4%) 153 (17·1%) 249 (8·7%) 0 <0·0001
Yes, surgically placed central line (open insertion) 254 (6·6%) 27 (3·0%) 227 (7·9%) 0 <0·0001
No 1910 (49·6%) 226 (25·2%) 1597 (55·8%) 87 (93·5%) <0·0001
Total duration of antibiotics after primary intervention, days 7 (3–11) 3 (1–7) 7 (3–13) 3 (0–7) 0·0001
Blood transfusion
Not required 2448 (63·6%) 671 (74·9%) 1708 (59·7%) 69 (74·2%) <0·0001
Yes 1348 (35·0%) 213 (23·8%) 1114 (38·9%) 21 (22·6%) ··
Required but not available 47 (1·2%) 9 (1·0%) 35 (1·2%) 3 (3·2%) ··
Missing 6 (0·1%) 3 (0·3%) 3 (0·1%) 0 ··
(Table 2 continues on next page)
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diaphragmatic hernia, 72 (51·1%) of 141 for oesophageal 
atresia, 49 (27·5%) of 178 for anorectal malformation, 
and 12 (11·2%) of 107 for Hirschsprung’s disease.
The proportions of patients followed up to 30 days 
post primary intervention to assess survival status and 
presence of complications are described in the appendix 
(p 45). Of 3849 study patients, 418 (10·9%) were still 
in hospital at 30 days post intervention. Of the 
2761 (71·7%) patients discharged home before 30 days, 
2495 (90·4%) were followed up to 30 days.
Overall all-cause, in-hospital mortality was 37 (39·8%) 
of 93 in low-income countries, 583 (20·4%) of 2860 in 
middle-income countries, and 50 (5·6%) of 896 in 
high-income countries, (p<0·0001 between all country 
income groups; figure 3, appendix p 46). For each con-
dition considered individually, gastroschisis, oesophageal 
atresia, and intestinal atresia also showed a significant 
difference between all income groups; congenital 
diaphragmatic hernia showed a significant difference 
between high-income countries and middle-income 
countries (there were too few patients from low-income 
countries to make a comparison); anorectal malforma-
tion had a significant difference between high-income 
countries and low-income countries, and high-income 
countries and middle-income countries, but not between 
middle-income countries and low-income countries; 
Hirschsprung’s disease and exomphalos showed no 
significant difference between country income groups 
(appendix p 46). Gastroschisis had the greatest difference 
in mortality (nine [90·0%] of ten in low-income countries, 
97 [31·9%] of 304 in middle-income countries, two [1·4%] 













(Continued from previous page)
Ventilation
No 1755 (45·6%) 258 (28·8%) 1422 (49·7%) 75 (80·6%) <0·0001
Yes 2008 (52·2%) 637 (71·1%) 1363 (47·7%) 8 (8·6%) ··
Required but not available 85 (2·2%) 1 (0·1%) 74 (2·6%) 10 (10·8%) ··
Missing 1 (<0·1%) 0 1 (<0·1%) 0 ··
Duration of ventilation if given, days 4 (2–8) 4 (2–9) 4 (2–8) 2 (1–3) 0·0025
Time to first enteral feed post-primary intervention, days 4 (2–8) 4 (2–8) 4 (2–8) 1 (1–3) <0·0001
Time to full enteral feeds post-primary intervention, days 8 (4–16) 11 (6–22) 7 (3–15) 3 (2–7) <0·0001
Parenteral nutrition
No 1476 (38·3%) 212 (23·7%) 1196 (41·8%) 68 (73·1%) <0·0001
Yes 2102 (54·6%) 683 (76·2%) 1416 (49·5%) 3 (3·2%) ··
Yes, but less was available than required 143 (3·7%) 0 143 (5·0%) 0 ··
Required but not available 125 (3·2%) 0 103 (3·6%) 22 (23·7%) ··
Missing 3 (0·1%) 1 (0·1%) 2 (0·1%) 0 ··
Duration of parenteral nutrition if received, days 11 (6–20) 14 (8–24) 10 (5–18) 30 (10–30) 0·0001
Data are n (%), median (IQR), or n. *p values represent univariable testing between country income strata.
Table 2: Care received by patients
Figure 3: All-cause, in-hospital mortality
Data are shown as percentages (95% CIs). Numbers of patients are shown in the appendix (p 46). Only one patient with congenital diaphragmatic hernia presented in 
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all country income groups), followed by congenital 
diaphragmatic hernia, oesophageal atresia, and intestinal 
atresia (figure 3, appendix p 46). Neonates accounted for 
658 (98·2%) of 670 deaths. Of note, all of the patients 
who did not receive an intervention had either been 
discharged alive or died within 30 days of admission.
On multivariable analysis of all study patients, 
country income status was associated with the highest 
risk of mortality (low-income vs high-income country, 
RR 2·78 [95% CI 1·88–4·11]; middle-income vs high-
income country, 2·11 [1·59–2·79]; figure 4). Congenital 
diaphragmatic hernia had the highest risk of mortality 
and Hirschsprung’s disease had the lowest.
Antenatal diagnosis and presence of an additional 
anomaly were associated with higher mortality; higher 
gestational age and bodyweight, and delivery via induced 
Figure 4: Multivariable analysis of factors affecting mortality (all patients and income settings)
Of 3849 study patients, 3735 were included within this multivariable model (n=114 excluded due to missing data). Additional anomaly includes additional study 
condition(s) if present. Further intervention refers to the need for unplanned re-intervention within 30 days of surgery. ASA=American Society of Anesthesiologists 
score at primary intervention. CDH=congenital diaphragmatic hernia. HIC=high-income country. LIC=low-income country. MIC=middle-income country. 
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vaginal birth or caesarean section were associated with 
lower mortality. For outborn patients, sepsis at presenta-
tion was associated with a higher mortality. At the time of 
primary intervention, mortality was higher for patients 
with a higher ASA score, with no physician anaesthetist 
present, and with a surgical safety checklist not used. 
In the perioperative period, not having ventilation or 
parenteral nutrition when required, needing or receiving 
ventilation or a blood transfusion, and undergoing 
a further unplanned intervention were associated 
with higher mortality. Receiving parenteral nutrition, a 
peripherally inserted central catheter, or a percutaneous 
central line were associated with lower mortality.
The multivariable analysis results of patients in LMICs 
were similar to those for all patients, except that 
gastroschisis was also significantly associated with higher 
mortality alongside congenital diaphragmatic hernia, and 
Hirschsprung’s disease was no longer significantly lower 
(appendix p 63). In the high-income country multivariable 
model, no individual condition had a significantly higher 
or lower risk of mortality compared with the study patients 
without that condition (appendix p 64). Delivery type, 
sepsis at presentation, ASA score, use of a surgical safety 
checklist, ventilation, parenteral nutrition, and central 
intravenous access were not significantly associated with 
mortality. By contrast, hypothermia and hypovolaemia at 
presen tation were associated with higher mortality.
On exploratory analysis of mortality by study condition, 
exomphalos was the only condition for which delivery 
method affected mortality risk (elective caesarean section vs 
spontaneous vaginal delivery, RR 0·25 [95% CI 0·12–0·54]; 
appendix pp 65–71). For congenital diaphragmatic hernia 
(0·63 [0·43–0·93]) and gastroschisis (0·58 [0·35–0·95]), 
birth at the study centre was associated with lower mortality 
compared with outborn patients.
30-day post-intervention mortality was similar to all-
cause in-hospital mortality, with the exception that an 
additional 11 patients died after discharge before 30 days 
in middle-income countries (appendix p 72). In patients 
who had surgery, surgical site infection rates did not 
differ across income settings, whereas wound dehiscence 
and further unplanned intervention differed statistically, 
although not substantially. Median hospital stay among 
survivors was lowest in low-income countries (9 days 
[IQR 5–18]), followed by middle-income countries 
(14 days [8–23]) and high-income countries (20 days 
[12–30]). Time to death among non-survivors was similar 
across settings (low-income countries, 6 days [3–12]; 
middle-income countries, 6 days [2–13]; high-income 
countries, 9 days [3–15]).
Overall, the leading causes of death were sepsis (n=235, 
35·1%) and respiratory failure (n=189, 28·2%; appendix 
p 73). Proportionally, sepsis caused more deaths in 
LMICs than in high-income countries.
Median observed agreement between the study and 
validation data was 100% (IQR 88–100; κ statistic 0·96 
[IQR 0·57–1·00]; appendix pp 74–75). Variables deemed 
potentially inaccurate were gestational age at birth, 
distance from home to study centre, and time from 
birth to presentation (appendix pp 76–79). Validators 
identified eight patients missed from study inclusion 
(appendix p 80).
Discussion
This international, prospective, cohort study has provided 
information on outcomes for almost 4000 patients with 
gastrointestinal congenital anomalies in 74 countries 
across the world. The study highlights substantial 
differences in mortality between low-income, middle-
income, and high-income countries. The chance of dying 
from a gastrointestinal congenital anomaly if born in a 
low-income country is two in five, compared with one in 
five in a middle-income country and one in 20 in a high-
income country. Neonates born with gastroschisis have 
the greatest mortality difference, with mortality of 90% 
in low-income countries and 32% in middle-income 
countries, compared with 1% in high-income countries. 
Thus, conditions associated with a normal lifespan for 
most individuals in high-income countries are frequently 
fatal within days of life for neonates born with the same 
conditions in LMICs. Tackling these inequities has the 
potential to reduce global neonatal mortality and is 
essential if preventable deaths in neonates are to be 
ended by 2030.15
Gastrointestinal congenital anomalies require surgical 
care, and our findings are consistent with previous 
studies that have shown far better surgical outcomes in 
high-income countries than in low-income or middle-
income countries.20–22 However, the notably high surgical 
mortality rates amongst neonates in our study far exceed 
those reported in LMICs for older children and adults 
requiring surgery (between 1% and 4%, depending 
on the study).20–22 The inequities that we have found 
highlight neonatal surgical care as a global health 
priority. Our findings fit with knowledge that surgery 
has been neglected in the global health field; indeed, a 
focus in LMICs on paediatric surgery, particularly 
neonatal surgery, has been almost non-existent.8
To our knowledge, this is the first comprehensive 
global outcomes study of gastrointestinal congenital 
anomalies. It confirms previous findings from smaller, 
mostly single-centre, retrospective studies. A systematic 
review of neonatal surgery in sub-Saharan Africa 
reported greater than 50% mortality for emergency 
gastrointestinal surgery compared with 3% mortality for 
spina bifida and cleft lip and palate surgery.9 A hospital in 
northern Ghana reported that 96% of neonatal surgical 
deaths were from congenital anomalies and two-thirds of 
such deaths involved gastrointestinal anomalies.23
Our results highlight that many patients in LMICs do 
not receive components of neonatal surgical care that 
are considered essential in high-income settings. These 
include antenatal diagnosis, birth at a paediatric surgery 
centre, effective resuscitation, timely ambulance transfer 
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for patients born in or referred to district hospitals, use 
of a surgical safety checklist, a physician anaesthetist at 
primary intervention, and basic neonatal intensive care 
unit resources such as ventilation, central intravenous 
access, and parenteral nutrition. Our large study cohort, 
across all income settings, enabled us to calculate the 
risk of mortality associated with receipt of, or lack of 
access to, these resources.
Our finding that antenatal diagnosis is associated with 
higher mortality is potentially misleading, simply 
reflecting easier antenatal detection of more severe 
cases.24 Indeed, on exploratory multivariable analyses, 
lower mortality was associated with birth at the study 
hospital for gastroschisis and congenital diaphragmatic 
hernia, and caesarean section for exomphalos, both 
enabled by antenatal diagnosis. Antenatal diagnosis 
enables delivery at a paediatric surgery centre, avoiding 
clinical deterioration before arrival and presentation in a 
poor clinical condition. Multiple indicators of poor 
clinical condition were significantly associated with 
higher mortality on multivariable analysis in LMICs: 
sepsis at presentation, higher ASA score at primary 
intervention, and a need for blood transfusion and 
ventilation. Although proportionally more patients who 
had an operation had better ASA scores in low-income 
countries and middle-income countries compared with 
high-income countries, this finding could reflect that the 
most sick patients in LMICs do not receive surgical 
intervention (and therefore an ASA score) and are 
palliated; competing priorities for limited resources and 
cost of surgery, which often requires out-of-pocket 
expenses for families in LMICs, might contribute to such 
decision making.25,26 Our study highlights that fewer 
women underwent antenatal ultrasound scanning in 
LMICs, and even when they did, the anomalies were less 
frequently detected than in high-income countries, 
highlighting the need for both increased access to and 
improved quality of antenatal ultrasound. A randomised 
controlled trial in five LMICs showed that increased 
antenatal ultrasound scanning is possible (95% of women 
in the intervention group vs 43% in the control group) 
and that 9·3% of scanned women were referred for an 
ultrasound-diagnosed condition (maternal and fetal).27 
However, the study authors found that increased antenatal 
diagnosis rates alone do not translate into increased 
hospital delivery or neonatal survival, emphasising the 
need for a systems approach targeting barriers to delivery 
at a paediatric surgery centre.28
Our study highlights that most patients with 
gastrointestinal congenital anomalies in LMICs are not 
born at the paediatric surgery centre; most are referred 
from district hospitals. Even in high-income countries, 
where 95% of the women received an antenatal 
ultrasound, not all anomalies were detected. Therefore, 
upskilling staff at district hospitals to deal with births at, 
or referrals to, these facilities is vital to prevent clinical 
deterioration before surgical intervention. Such an 
initiative in India showed successful knowledge and 
skills transfer by multidisciplinary paediatric surgical 
teams to district hospitals.29 Unfortunately, the 2017 WHO 
recommendations on newborn health include a section 
on management of “other severe conditions”, but do not 
mention congenital anomalies.30 Therefore, upgrading 
this document will be an important step for knowledge 
dissemination. Similarly, management of neonates with 
congenital anomalies should be incorporated within 
national WHO Every Newborn Action Plans, with a 
particular focus on the prevention of sepsis, hypothermia 
and hypovolaemia.31 Our study also showed that patients 
in LMICs travel further to hospitals and present later, 
frequently without hospital transport. Although they were 
not independently significantly associated with mortality, 
these factors probably also affect the clinical condition of 
patients on arrival, highlighting the need for improved 
access to timely and effective inter-hospital transportation.
At paediatric surgery centres, we identified a number 
of factors that were independently associated with 
mortality in the preoperative, intraoperative, and 
perioperative periods. Poorer clinical condition was 
associated with higher mortality, which could potentially 
be addressed through improved resuscitation on arrival. 
Our results show that not all septic and hypovolaemic 
patients received intravenous antibiotics and fluids 
within an hour of arrival, and some hypothermic patients 
were not warmed. The absence of a physician anaesthetist 
at the primary intervention and not using a surgical 
safety checklist were associated with a higher mortality. 
To address the absence of physician anaesthetists, the 
charity KidsOR has recently pledged funds to train 
paediatric anaesthetists alongside paediatric surgeons 
across Africa. Efforts are required to broaden the use of 
surgical safety checklists in LMICs; the use of imple-
mentation science techniques may help to improve this.32 
In the perioperative period, non-availability of ventilation 
and parenteral nutrition when required was significantly 
associated with high mortality in LMICs, whereas receipt 
of parenteral nutrition and peripheral or percutaneous 
central intra venous access were associated with lower 
mortality.
Basic neonatal intensive care facilities have been omitted 
from previous global neonatal care recommendations 
because they are deemed expensive.1 However, these 
resources are essential, not only for surgical neonates, but 
also for many low-birthweight and sick neonates due to 
other causes, and they should be included in long-term 
strategies for LMICs. Such interventions lend themselves 
to innovative solutions, as seen with the rapid development 
of low-technology, cost-effective ventilation methods 
during the COVID-19 pandemic.33 The need for intensive 
care resources can also be reduced through context-
optimised surgical techniques, such as cotside bowel 
reduction and sutureless closure of gastroschisis using a 
preformed silo, which reduces the need for ventilation.34 
These techniques are currently being trialled in a 
For more on KidsOR see 
https://www.kidsor.org
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multicentre, multinational interventional study in sub-
Saharan Africa, alongside locally sourced, affordable, 
peripherally administered, partial parenteral nutrition, 
which could benefit neonatal outcomes more broadly.35
This study has several limitations. For feasibility, the 
study focused on a selection of common, high-mortality, 
gastrointestinal congenital anomalies rather than the full 
complement of anomalies. Despite the study being 
intentionally designed to minimise reporting burden for 
high-volume, low-resource centres, the proportion of 
patients included from low-income countries (2%) was 
lower than in the global population (9%).36 However, the 
proportion of study patients from middle-income 
countries (74%) reflects the global middle-income country 
population (75%).36 Although the number of patients 
included from low-income countries was relatively low, 
the mortality rates that we found reflect what has 
previously been reported in the scarce data available from 
these regions. For example, two of the largest single-
centre observational studies on gastroschisis in low-
income countries reported a mortality of 90% (136 of 151) 
in Uganda and 84% (80 of 95) in Zimbabwe.37,38 The 
Gastroschisis Interventional Study across seven tertiary 
paediatric surgery centres in Ghana, Zambia, Malawi, 
and Tanzania (low-income countries and lower-middle 
income countries) reported an overall baseline mortality 
of 95%.35 Mortality rates for the other study conditions are 
also similar to those reported from Uganda.38
Despite the higher mortality rates in LMICs compared 
with high-income countries, the reported mortality 
could be an underestimation for several reasons. Data 
collection was done at paediatric surgery centres; some 
patients might have died without reaching such care in 
LMICs.39 This is evidenced by the missing patients with 
congenital diaphragmatic hernia, particularly within the 
low-income country cohort, and the under-representation 
of gastroschisis within the LMIC cohorts; such under-
reporting also occurred in high-income countries in 
the 1970s.40 Cases with more advanced disease severity 
(eg, severe congenital diaphragmatic hernia) or multiple 
anomalies (eg, coexisting cardiac anomaly) might be 
more likely to die before presentation in LMICs (or not 
get referred). This situation would account in part for 
the higher proportion of patients with an ASA score of 1 
in low-income countries and of 2 in middle-income 
countries compared with high-income countries, and 
also the lower proportion of patients with associated 
anomalies in low-income countries. However, the lower 
proportion of associated anomalies might also result 
from underdiagnosis due to lower diagnostic expertise 
and resources in low-income countries. If more than 
20% of patients were missing the primary outcome in 
any given month at a participating hospital, all patients 
in that month were excluded. Although we used this 
strategy to optimise the accuracy of mortality estimates, 
it could have inadvertently introduced bias if poorer data 
collection is associated with poorer outcomes. However, 
no participating hospitals were excluded as a result, and 
only 14 months of data (37 patients) were excluded 
compared with 962 months of data (3849 patients) 
included in the study. Therefore, the effect is likely to be 
small. 30-day post-intervention follow-up was missing in 
37·5% of patients in low-income countries, 9·0% of 
patients in middle-income countries, and 7·5% of 
patients in high-income countries; therefore, some post-
discharge deaths and complications were potentially 
missed.
There are some additional factors to consider when 
interpreting the study data. Although we identified 
multiple factors associated with mortality through robust 
multivariable analyses, our findings regarding the causes 
of death are less robust. Cause of death was determined 
via clinical diagnosis of the treating physician, which is 
commonly multifactorial and difficult to confirm with 
certainty. However, our findings are consistent with the 
Lancet Newborn Series, which also reported sepsis to be 
the leading global cause of death in neonates more 
broadly.1 ASA scoring could have inter-rater variability in 
different regions of the world. Our multivariable model 
of patients with exomphalos included both minor and 
major variants; elective caesarean section is commonly 
confined to major variants. In low-income countries, 
most cases of Hirschsprung’s disease were diagnosed 
clinically without biopsy confirmation; a lack of diag-
nostic facilities could result in missed patients and also 
inclusion of patients without the condition. Centralisation 
of care within and between paediatric surgery centres 
and multidisciplinary team care has played a key role in 
optimising outcomes in high-income countries, but it 
has not been captured within this study. In high-
income countries and some middle-income countries 
where antenatal detection is higher, some fetuses with 
more severe or multiple anomalies might have been 
terminated, contributing to the lower mortality. However, 
this situation is not reflected in the data because high-
income countries had the highest proportion of patients 
with additional anomalies, followed by middle-income 
countries. For feasibility and to focus on neonatal 
mortality, the follow-up period was limited to 30 days; 
longer-term follow-up is required to determine disability 
and quality of life.
This study provides evidence that Sustainable Develop-
ment Goal 3.2 to end preventable deaths in neonates and 
children younger than 5 years by 2030 is unachievable 
without urgent action to improve neonatal surgical care 
in LMICs.15 The comprehensive study design and large 
cohort enabled identification of factors associated with 
mortality that can be addressed through improvements 
in antenatal and district-level care, and care at paediatric 
surgery centres. Strong collaboration between obstetric, 
neonatal, surgical, anaesthetic, and nursing teams is 
required. The Global Initiative for Children’s Surgery 
provides such a platform, and the newly formed 
Congenital Anomalies Working Group focuses on 
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